| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.46 | 0.004 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.45 | 0.005 |